Associated Papers
Spectrum of Mechanisms of Resistance to Crizotinib and Lorlatinib in ROS1 Fusion-Positive Lung Cancer.
Lin JJ et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2021
Select a paper to view details